Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 9/20 | 0.84 |
| ▸ | HPGD | P15428 | 1/20 | 0.84 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.79 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.79 |
| ▸ | HCAR2 | Q8TDS4 | 3/20 | 0.61 |
| ▸ | ATM | Q13315 | 1/20 | 0.57 |
| ▸ | NAAA | Q02083 | 1/20 | 0.55 |
| ▸ | TP53 | P04637 | 2/20 | 0.54 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.54 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.49 |
| ▸ | RAD52 | P43351 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | FAAH | O00519 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10868277 | 1.00 | TSHR (0.84) | TSHRHPGDALDH1A1CYP3A4HCAR2 | |
| SCHEMBL16669730 | 1.00 | TSHR (0.84) | TSHRHPGDALDH1A1CYP3A4HCAR2 | |
| SCHEMBL877669 | 1.00 | TSHR (0.84) | TSHRHPGDALDH1A1CYP3A4HCAR2 | |
| SCHEMBL14574685 | 1.00 | TSHR (0.84) | TSHRHPGDALDH1A1CYP3A4HCAR2 | |
| SCHEMBL14967 | 1.00 | TSHR (0.84) | TSHRHPGDALDH1A1CYP3A4HCAR2 | |
| SCHEMBL9442075 | 1.00 | TSHR (0.84) | TSHRHPGDALDH1A1CYP3A4HCAR2 | |
| SCHEMBL811560 | 1.00 | TSHR (0.84) | TSHRHPGDALDH1A1CYP3A4HCAR2 | |
| SCHEMBL21218910 | 1.00 | TSHR (0.84) | TSHRHPGDALDH1A1CYP3A4HCAR2 | |
| SCHEMBL22607678 | 1.00 | TSHR (0.84) | TSHRHPGDALDH1A1CYP3A4HCAR2 | |
| SCHEMBL7647533 | 1.00 | TSHR (0.84) | TSHRHPGDALDH1A1CYP3A4HCAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12534663-B2 | Re-crosslinkable hyper-branched polymer gels based on a transamidation reaction | THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) | 2026-01-27 | — | — | US | claimed |
| WO-2025226939-A1 | ENHANCED SENSATION CONDOM | NUCEPTIVE LABS, INC. (US) | 2025-10-30 | — | — | WO | claimed |
| EP-4608465-A1 | ENHANCED SENSATION CONDOM | Nuceptive Labs, Inc. (US) | 2025-09-03 | — | — | EP | claimed |
| EP-4608466-A1 | STIMULI-RESPONSIVE MEDICAL ADHESIVE COMPOSITIONS, ARTICLES, AND METHODS | Nuceptive Labs, Inc. (US) | 2025-09-03 | — | — | EP | claimed |
| CN-118768564-B | High-flow low-ash binder for metal injection molding and preparation method thereof | 开禾科技(宁波)有限公司 | 2024-11-12 | — | — | CN | claimed |
| CN-118768564-A | High-flow low-ash binder for metal injection molding and preparation method thereof | 开禾科技(宁波)有限公司 | 2024-10-15 | — | — | CN | claimed |
| CN-118421154-A | Environment-adaptive water-based durable short-chain fluorine-containing water-repellent oil-repellent paint, and preparation method and application thereof | 四川大学 | 2024-08-02 | — | — | CN | claimed |
| WO-2024092174-A1 | STIMULI-RESPONSIVE MEDICAL ADHESIVE COMPOSITIONS, ARTICLES, AND METHODS | NUCEPTIVE LABS, INC. (US) | 2024-05-02 | — | — | WO | claimed |
| WO-2024092168-A1 | ENHANCED SENSATION CONDOM | NUCEPTIVE LABS, INC. (US) | 2024-05-02 | — | — | WO | claimed |
| US-20240132771-A1 | RE-CROSSLINKABLE HYPER-BRANCHED POLYMER GELS BASED ON A TRANSMIDATION REACTION | THE CURATORS OF THE UNIVERSITY OF MISSOURI | 2024-04-25 | — | — | US | claimed |
| CN-114920871-B | Optical-grade polymethyl methacrylate resin and application thereof | 万华化学集团股份有限公司 | 2023-09-19 | — | — | CN | claimed |
| EP-4240804-A1 | RE-CROSSLINKABLE HYPER-BRANCHED POLYMER GELS BASED ON A TRANSMIDATION REACTION | The Curators Of The University Of Missouri (US) | 2023-09-13 | — | — | EP | claimed |
| WO-2022098411-A1 | RE-CROSSLINKABLE HYPER-BRANCHED POLYMER GELS BASED ON A TRANSMIDATION REACTION | THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) | 2022-05-12 | — | — | WO | claimed |
| US-5015406-A | Pour points, viscosity and viscosity index improving polymers | CONOCO (US) | 1991-05-14 | — | — | US | claimed |
| US-4954135-A | Oil compositions containing terpolymers of alkyl acrylates or methacrylates, an olefinically unsaturated homo or heterocyclic-nitrogen compound and allyl acrylates or methacrylates | CONCO INC. (US) | 1990-09-04 | — | — | US | claimed |
| US-4900569-A | POUR POINT DEPRESSANT | CONOCO INC. (US) | 1990-02-13 | — | — | US | claimed |
| US-4886520-A | POUR POINT DEPRESSANTS | CONOCO, INC. (US) | 1989-12-12 | — | — | US | claimed |
| EP-4743035-A1 | A FUNCTIONAL PACKAGE FOR AN ADHESIVE | Nuceptive Labs, Inc. (US) | 2026-05-20 | — | — | EP | disclosed |
| US-4900569-A | POUR POINT DEPRESSANT | CONOCO INC. (US) | 1990-02-13 | — | — | US | disclosed |
| US-4886520-A | POUR POINT DEPRESSANTS | CONOCO, INC. (US) | 1989-12-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12534663-B2 | Re-crosslinkable hyper-branched polymer gels based on a transamidation reaction | PHOSPHO1, TERT, AS3MT | TSHR 488/4885HPGD 2847/4885ALDH1A1 2931/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.